L.L. News and Research

RSS

UA researcher develops new method to monitor frailty symptoms

A layperson might think of "frail" as simply a synonym for "weak" or "fragile." But in the medical field, frailty is a specific term, meaning – due to factors including inflammation and hormone shifts – a patient has a lack of physiological reserve, or a reduced ability to tolerate stress.

23 Jun 2023

AHA awards $20 million to address health challenges in rural communities

People who live in rural areas of the U.S. are 40% more likely to develop heart disease and have a 30% higher risk of stroke than people who live in urban areas, according to data reported in the 2020 Call to Action: Rural Health: A Presidential Advisory From the American Heart Association and American Stroke Association.

23 Jun 2023

Rice U. chemist wins NSF award to investigate how heterogeneity affects chemical and biological processes

Rice University chemist Anatoly Kolomeisky has won an award from the National Science Foundation to investigate how heterogeneity affects chemical and biological processes.

16 Jun 2023

New approach improves diagnosis of limb-girdle muscular dystrophy

It's not easy to distinguish between the dozens of subtypes of limb girdle muscular dystrophy - a rare, genetic muscle disease characterized by weakness in the hips and shoulders that causes difficulty walking and lifting the arms.

15 Jun 2023

KU investigator develops treatment for stroke, heart disease, other metabolic diseases

An investigator with the University of Kansas School of Pharmacy has filed an invention disclosure, part of a provisional patent application with the United States Patent and Trademark Office, for a treatment that could apply to heart disease, stroke and a host of other human diseases related to metabolism.

15 Jun 2023

Scientists show how pregnancy induces progressive changes in the maternal immune system

We have a good understanding of how a woman's external features can change during pregnancy, but scientists know surprisingly little about what biological changes occur internally.

13 Jun 2023

Molecule found in the venomous toadfish controls lung inflammation in mice

A molecule found in the venomous toadfish Thalassophryne nattereri has proved capable of controlling lung inflammation and could be the basis for a more effective asthma drug.

13 Jun 2023

10 postdoctoral fellows from Latin America receive Pew funding for biomedical research

The Pew Charitable Trusts today announced the 2023 class members of the Pew Latin American Fellows Program in the Biomedical Sciences.

13 Jun 2023

UCL researchers produce first image of the structures that power human cilia

The first image of the structures that power human cilia – the tiny, hairlike projections that line our airways – has been produced by a team involving UCL researchers and could lead to much-needed treatments for people with rare cilial diseases.

13 Jun 2023

Researchers identify a potential breakthrough in glioblastoma treatment

In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program at Huntsman Cancer Institute, identified a potential breakthrough in glioblastoma treatment.

12 Jun 2023

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Drugs used to treat rare conditions are earning pharmaceutical companies almost as much as those marketed to the general public, according to a researcher at West Virginia University. Sean Tu, a College of Law professor found lucrative so-called "orphan" drugs earn manufacturing tax credits, have longer patent exclusivities and face easier Food and Drug Administration review.

12 Jun 2023

Scientists determine the atomic-level structure of a zinc-transporter protein

Scientists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have determined the atomic-level structure of a zinc-transporter protein, a molecular machine that regulates levels of this crucial trace metal micronutrient inside cells.

9 Jun 2023

Study offers new insights into the rapid spread of fraudulent Medicare home healthcare billing

Findings from an innovative study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and published in the journal Social Science & Medicine, are providing new insights into how the rapid spread (or diffusion) of fraudulent Medicare home healthcare billing has occurred across the U.S. in recent years.

8 Jun 2023

Teaming up with the patient’s immune system to combat cancer

The fact that our immune systems capture and destroy nanoparticles and the drugs they carry has been a problem in the field of nanomedicine for some time. But, in the fight against cancer, researchers are now attempting to exploit this problem to their advantage.

8 Jun 2023

Microparticle-delivered therapy likely to be the first step toward stopping autoimmune diseases

According to the federal government's National Institute of Neurological Disorders and Stroke, nearly 3 million people worldwide - with almost a third in the United States - are living with multiple sclerosis (MS), a disabling neurological disease in which the body's immune system mistakenly attacks nerves feeding information to the central nervous system (the brain and spinal cord). Although rarely fatal, MS can lead to long-term disabilities, and impair movement, muscle control, vision and cognition.

6 Jun 2023

Researchers characterize a unique molecular mechanism of early stages of programmed cell death

Researchers have for the first time characterized a unique molecular mechanism of the early stages of programmed cell death or apoptosis, a process which plays a crucial role in prevention of cancer.

2 Jun 2023

Exposure to Agent Orange associated with increased risk of myeloproliferative neoplasms in veterans

Research conducted at Georgetown University's Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins.

2 Jun 2023

L.L. News and Research

UA researcher develops new method to monitor frailty symptoms

AHA awards $20 million to address health challenges in rural communities

Rice U. chemist wins NSF award to investigate how heterogeneity affects chemical and biological processes

New approach improves diagnosis of limb-girdle muscular dystrophy

KU investigator develops treatment for stroke, heart disease, other metabolic diseases

Scientists show how pregnancy induces progressive changes in the maternal immune system

Molecule found in the venomous toadfish controls lung inflammation in mice

10 postdoctoral fellows from Latin America receive Pew funding for biomedical research

UCL researchers produce first image of the structures that power human cilia

Researchers identify a potential breakthrough in glioblastoma treatment

So-called “orphan” drugs earn pharmaceutical companies as much money as mainstream medicines

Scientists determine the atomic-level structure of a zinc-transporter protein

Study offers new insights into the rapid spread of fraudulent Medicare home healthcare billing

Teaming up with the patient’s immune system to combat cancer

Microparticle-delivered therapy likely to be the first step toward stopping autoimmune diseases

Researchers characterize a unique molecular mechanism of early stages of programmed cell death

Exposure to Agent Orange associated with increased risk of myeloproliferative neoplasms in veterans

Research on the first-ever human pangenome reference helps better understand chromosome biology

As Medicaid purge begins, ‘Staggering numbers’ of Americans lose coverage

California governor and Democratic lawmakers at odds over billions in health care funds

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News